Involvement of protein kinase C and phosphatidylinositol 3-kinase pathways in the survival of B-cell chronic lymphocyticleukemia cells

Blood

Volumn 99, Issue 8, 2002, Pages 2969-2976

  Barragán, Montserrat ^a,b   Bellosillo, Beatriz ^a,b   Campàs, Clara ^a,b   Colomer, Dolors ^a,b   Pons, Gabriel ^a,b   Gil, Joan ^a,b  

^a UNIVERSITY OF BARCELONA   (Spain)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

2 MORPHOLINO 8 PHENYLCHROMONE; DEXAMETHASONE; FLUDARABINE; INTERLEUKIN 4; MITOGEN ACTIVATED PROTEIN KINASE INHIBITOR; PHORBOL 13 ACETATE 12 MYRISTATE; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHATIDYLINOSITOL 3 KINASE INHIBITOR; PROTEIN KINASE B; PROTEIN KINASE C; PROTEIN KINASE C INHIBITOR;

ADULT; AGED; APOPTOSIS; ARTICLE; B CELL LEUKEMIA; CELL SURVIVAL; CELL VIABILITY; CHRONIC LYMPHATIC LEUKEMIA; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME INHIBITION; FEMALE; HUMAN; LEUKEMIA CELL; MALE; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION;

EID: 0037089403     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.V99.8.2969     Document Type: Article

References (61)

1. Chronic lymphocytic leukemia
2. Chronic lymphocytic leukemia
3. Molecular biology of chronic lymphocytic leukemia
4. The cellular biology of B-cell chronic lymphocyticleukemia
5. Spontaneous programmed death (apoptosis) of B-chroniclymphocytic leukaemia cells following their culture in vitro
6. Interleukin 4 protects chronic lymphocytic leukemic Bcells from death by apoptosis and upregulates Bcl-2 expression
7. Interleukin-4 inhibits apoptotic cell death and loss of the bcl-2protein in B-chronic lymphocytic leukaemia cells in vitro
8. Interferon gamma inhibits apoptotic cell death in B cell chronic lymphocytic leukemia
9. Alpha-interferon (alpha-IFN) protects B-chronic lymphocytic leukaemia cells from apoptotic cell death in vitro
10. Interleukin-2 prevents programmed cell death in chronic lymphocytic leukemia cells
11. Interleukin-6 inhibits apoptosis and tumour necrosis factor induced proliferation of B-chronic lymphocytic leukaemia
12. Interleukin-8 induces the accumulation of B-cell chronic lymphocytic leukemia cells by prolonging survival in an autocrine fashion
13. Interleukin-13 inhibits interleukin-2-induced proliferation and protects chronic lymphocytic leukemia B cells from in vitro apoptosis
14. Blood-derived nurse-like cells protect chronic lymphocytic leukemia B cells from spontaneous apoptosis through stromal cell-derived factor-1
15. Cytokine gene expression in B-cell chronic lymphocytic leukemia: Evidence of constitutive interleukin-8 (IL-8) mRNA expression and secretion of biologically active IL-8 protein
16. The levels of TNFα, IL4 and IL10 production by T-cells in B-cell chronic lymphocytic leukaemia (B-CLL)
17. Involvement of CED-3/ICE proteases in the apoptosis of B-chronic lymphocytic leukemia cells
18. Interleukin-5 (IL-5) increases spontaneous apoptosis of B-cell chronic lymphocytic leukemia cells in vitro independently of bcl-2 expression and is inhibited by IL-4
19. Interleukin 10 induces apoptotic cell death of B-chronic lymphocytic leukemia cells
20. Theophylline synergizes with chlorambucil in inducing apoptosis of B-chronic lymphocytic leukemia cells
21. Flavopiridol induces apoptosis in chronic lymphocytic leukemia cells via activation of caspase-3 without evidence of bcl-2 modulation or dependence on functional p53
22. Serine/threonine protein kinases and apoptosis
23. Cellular survival: A play in three Akts
24. Molecular signals in anti-apoptotic survival pathways
25. Phorbol ester-induced loss of colchicine ultrasensitivity in chronic lymphocytic leukaemia lymphocytes
26. Induction of DNA fragmentation in chronic B-lymphocytic leukemia cells
27. Induction of apoptosis in chronic lymphocytic leukemia cells and its prevention by phorbol ester
28. Induction of apoptotic cell death in chronic lymphocytic leukemia by 2-chloro-2′-deoxyadenosine and 9-beta-D-arabinosyl-2-fluoroadenine
29. Bryostatin and CD40-ligand enhance apoptosis resistance and induce expression of cell survival genes in B-cell chronic lymphocytic leukaemia
30. Protein kinase C alpha activates RAF-1 by direct phosphorylation
31. Activation of the mitogen-activated protein kinase/extracellular signal-regulated kinase pathway by conventional, novel, andatypical protein kinase C isotypes
32. The IL-4 receptor: Signaling mechanisms and biologic functions
33. Requirement for phosphatidylinositol-3 kinase in the prevention of apoptosis by nerve growth factor
34. Aspirin and salicylate induce apoptosis and activation of caspases in B-cell chronic lymphocytic leukemia cells
35. Effect of TPA on fructose 2,6-bisphosphate levels and protein kinase C activity in B-chronic lymphocytic leukemia (B-CLL)
36. Studies with synthetic peptide substrates derived from the neuronal protein neurogranin reveal structural determinants of potency and selectivity for protein kinase C
37. Phosphorylation of the MARCKS family of protein kinase C substrates in human B chronic lymphocytic leukemia cells
38. The bisindolylmaleimide GF 109203X is a potent and selective inhibitor of protein kinase C
39. Characterization and purification of a protein kinase C substrate in human B cells: Identification as lymphocyte-specific protein 1 (LSP1)
40. Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis
41. Identification of a novel inhibitor of mitogen-activated protein kinase kinase
42. Specificity and mechanism of action of some commonly used protein kinase inhibitors
43. A specific inhibitor ofphosphatidylinositol 3-kinase,2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one (LY294002)
44. Protein kinase inhibitors flavopiridol and 7-hydroxy-staurosporine down-regulate antiapoptosis proteins in B-cell chronic lymphocytic leukemia
45. Modulation of NF-kappa B activity and apoptosis in chronic lymphocytic leukemia B cells
46. Phorbolester-induced differentiation of chronic lymphocytic leukaemia cells
47. c-Cbl istyrosine-phosphorylated by interleukin-4 and enhances mitogenic and survival signals of interleukin-4 receptor by linking with thephosphatidylinositol 3′-kinase pathway
48. Xid-like immunodeficiency in mice with disruption of the p85α subunit of phosphoinositide 3-kinase
49. Impaired B cell development and proliferation in absence of phosphoinositide 3-kinase p85α
50. Transduction of interleukin-2 antiapoptotic and proliferative signals via Akt protein kinase
51. NF-κB activation by tumour necrosis factor requires the Aktserine-threonine kinase
52. Cytokine-induced apoptosis in epithelial HT-29 cells is independent of nitric oxideformation: Evidence for an interleukin-13-driven phosphatidylinositol 3-kinase-dependent survival mechanism
53. Interleukin-6 inhibits transforming growth factor-beta-induced apoptosis through the phosphatidyl-inositol 3-kinase/Akt and signal transducers and activators of transcription 3 pathways
54. Protein kinase C isotypes controlled by phosphoinositide 3-kinase through the protein kinase PDK1
55. Interleukin-3-induced phosphorylation of BAD throughthe protein kinase Akt
56. Akt phosphorylation of BAD couples survival signals to the cell-intrinsic death machinery
57. Regulation of cell death protease caspase-9 by phosphorylation
58. Expression of apoptosis-regulating proteins in chronic lymphocytic leukemia: Correlations with in vitro and in vivo chemoresponses
59. Akt promotes cell survival by phosphorylating and inhibiting a forkhead transcription factor
60. Expression of the proapoptotic Bcl-2 family member Bim isregulated by the forkhead transcription factor FKHR-L1
61. Identification of CISK, a new member of the SGK kinase family that promotes IL-3-dependent survival